製剤 (JP Patent Analysis Report)
The Technical Field "製剤" had 23 patent application filings in the most recent period (2023-01-01 to 2023-02-28). This is a significantly decreased of -203 filings (-89.8%) over 226 they had in the same period of the previous year (2022-01-01 to 2022-02-28). This report also includes technical terms related to " 医薬品製剤 ", " 医薬製剤 " in the search set.
The highest number of filings in 2017 with 3,012 cases, and their lowest number in 2022 with 1,628 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 11,393 cases in total) is 1,899, and the median is 2,157. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
| Index | Value |
|---|---|
| Average | 1,899 patents |
| Std Dev | 865 |
| COV | 0.5 |
The number of filings has been decreasing for the last 3 years (2020 to 2023).
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 1,628 cases | -25.70 % |
| 2021 year | 2,191 cases | +3.20 % |
| 2020 year | 2,123 cases | -19.09 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 製剤 for the period of the last 10 years (2014-01-01 to 2024-10-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 製剤, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
Introduction
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
製剤, Changes in the Number of JP Patents/Patent Applications
The changes in the number of patent filings of 製剤 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Search Set (Analysis Patents)
This patent analysis report was created for a patent search set of 22,394 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
製剤
Same industry / competition company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 製剤 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Comparing the number of applications of each company, ノバルティスアーゲー has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 19 cases, followed by 大正製薬株式会社 with 9 cases.
| Name | Cases |
|---|---|
| ノバルティスアーゲー | 19 cases |
| 大正製薬株式会社 | 9 cases |
| ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング | 8 cases |
| ジェネンテックインコーポレイテッド | 7 cases |
| 興和株式会社 | 6 cases |
| ライオン株式会社 | 4 cases |
| メルクパテントゲゼルシャフトミットベシュレンクテルハフツング | 3 cases |
| 武田薬品工業株式会社 | 2 cases |
| ビーエーエスエフソシエタス・ヨーロピア | 2 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Comparing the number of applications of each company, ノバルティスアーゲー has the highest number of joint applications in the last for the target period (2014 to 2024) with 241 cases, followed by ジェネンテックインコーポレイテッド with 220 cases.
| Name | Cases |
|---|---|
| ノバルティスアーゲー | 241 cases |
| ジェネンテックインコーポレイテッド | 220 cases |
| 興和株式会社 | 147 cases |
| ライオン株式会社 | 123 cases |
| ビーエーエスエフソシエタス・ヨーロピア | 121 cases |
| 大正製薬株式会社 | 97 cases |
| ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング | 89 cases |
| 武田薬品工業株式会社 | 75 cases |
| メルクパテントゲゼルシャフトミットベシュレンクテルハフツング | 66 cases |
| 日東電工株式会社 | 34 cases |
Same industry / competition company, Change in the Number of JP Patents
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
Top company information (JP)
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 製剤 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Trends in filing of joint patent applications in the last 3 years (2022 to 2024).
Among the top coapplicants, ノバルティスアーゲー has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 19 cases, followed by 興和株式会社 with 6 cases.
| Name | Cases |
|---|---|
| ノバルティスアーゲー | 19 cases |
| 興和株式会社 | 6 cases |
| ライオン株式会社 | 4 cases |
| 武田薬品工業株式会社 | 2 cases |
| ビーエーエスエフソシエタス・ヨーロピア | 2 cases |
Trends in filing of joint patent applications for the target period (2014 to 2024).
Among the top coapplicants, ノバルティスアーゲー has the highest number of joint applications in the last for the target period (2014 to 2024) with 241 cases, followed by 興和株式会社 with 147 cases.
| Name | Cases |
|---|---|
| ノバルティスアーゲー | 241 cases |
| 興和株式会社 | 147 cases |
| ライオン株式会社 | 123 cases |
| ビーエーエスエフソシエタス・ヨーロピア | 121 cases |
| 武田薬品工業株式会社 | 75 cases |
| 日東電工株式会社 | 34 cases |
Top company, Change in the Number of JP Patents
Below is a ranking of the number of JP patent applications by 製剤’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 製剤’s top 7 coapplicants over the last 20 years.
Top company Details (JP)
Trends in filing of joint patent applications with ノバルティスアーゲー
製剤 filed 241 joint applications with ノバルティスアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 105 cases in total) is 17.5, and the median is 18.5. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2016 with 39 cases, and their lowest number in 2021 with 14 cases.
| Index | Value |
|---|---|
| Average | 17.5 patents |
| Std Dev | 9.3 |
| COV | 0.5 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 19 cases | +35.7 % |
| 2021 year | 14 cases | -22.22 % |
| 2020 year | 18 cases | -25.00 % |
Trends in filing of joint patent applications with 武田薬品工業株式会社
製剤 filed 75 joint applications with 武田薬品工業株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 38 cases in total) is 6.3, and the median is 7.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2016 with 13 cases, and their lowest number in 2022 with 2 cases.
| Index | Value |
|---|---|
| Average | 6.3 patents |
| Std Dev | 4.0 |
| COV | 0.6 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 2 cases | -75.0 % |
| 2021 year | 8 cases | -20.00 % |
| 2020 year | 10 cases | -9.09 % |
Trends in filing of joint patent applications with ビーエーエスエフソシエタス・ヨーロピア
製剤 filed 121 joint applications with ビーエーエスエフソシエタス・ヨーロピア for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 33 cases in total) is 5.5, and the median is 5.5. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 31 cases, and their lowest number in 2022 with 2 cases.
| Index | Value |
|---|---|
| Average | 5.5 patents |
| Std Dev | 4.0 |
| COV | 0.7 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 2 cases | -75.0 % |
| 2021 year | 8 cases | +167 % |
| 2020 year | 3 cases | -66.7 % |
Trends in filing of joint patent applications with 興和株式会社
製剤 filed 147 joint applications with 興和株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 71 cases in total) is 11.8, and the median is 4.0. The coefficient of variation (standard deviation/mean) is 1.2, and there have been very big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2018 with 43 cases, and their lowest number in 2022 with 3 cases.
| Index | Value |
|---|---|
| Average | 11.8 patents |
| Std Dev | 14.8 |
| COV | 1.2 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 3 cases | -40.0 % |
| 2021 year | 5 cases | +66.7 % |
| 2020 year | 3 cases | -81.2 % |
Trends in filing of joint patent applications with ライオン株式会社
製剤 filed 123 joint applications with ライオン株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 53 cases in total) is 8.8, and the median is 6.5. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2014 with 20 cases, and their lowest number in 2022 with 4 cases.
| Index | Value |
|---|---|
| Average | 8.8 patents |
| Std Dev | 7.0 |
| COV | 0.8 |
| Year | Cases | YOY |
|---|---|---|
| 2022 year | 4 cases | -20.00 % |
| 2021 year | 5 cases | -37.5 % |
| 2020 year | 8 cases | -60.0 % |
Information on important patents (JP)
The following shows JP patents held by 製剤 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 製剤’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 製剤 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
Glossary
- Cited
- Indicates that the patent/patent application has been cited (by Examiners) in notices of reasons for rejection in the examination process of other (Japanese, U.S., or European) patent applications. The higher the number of citations, the more important the patent/patent application is considered to be.
- Request for invalidation trial
- Indicates that a third party has requested a procedure to invalidate the patent. It is likely to affect the business of third parties and is considered to be of high importance.
- Opposition
- Indicates that a third party has filed a petition with the Patent Office to hear the validity of the patent again. Like the trial for invalidation, it is considered to be of high importance.
- Information provision
- Indicates that a third party has provided the Patent Office with useful information for examination for the patent filed. It is usually considered to be of high importance because it is done to prevent the patent from being granted.
- Browsing request
- Indicates that a third party has requested the Patent Office to view the patent bag (a set of documents exchanged between the Patent Office and the applicant). The bag is often checked prior to trial for invalidation, opposition, and provision of information, and is considered to be a highly important patent.
Invalidationed Trial cases
List of latest Invalidationed Trial patents
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 6 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.5 times. The most recently Invalidation Trial patent is 特許7194153 "新規製剤" (Invalidation Trial day 2023-07-21) , next is 特許4171216 "含硫化合物と微量金属元素を含む輸液製剤" (Invalidation Trial day 2023-05-30) .
| - | No. | Title | Invalidation Trial days |
|---|---|---|---|
| 1 | 特許7194153 | 新規製剤 | 2023-07-21 |
| 2 | 特許4171216 | 含硫化合物と微量金属元素を含む輸液製剤 | 2023-05-30 |
| 3 | 特許6896700 | ワクチン組成物 | 2023-01-27 |
| 4 | 特許6236167 | 医薬品 | 2023-01-13 |
| 5 | 特許6244038 | 医薬製剤 | 2023-01-13 |
| 6 | 特許6950966 | スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法 | 2022-01-17 |
Top Patents/Patent Applications with the Highest Number of Invalidationed Trial
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 9 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.0. The most invalidation trial patent is 特許6522072 "イズロン酸−２−スルファターゼのＣＮＳ送達のための方法および組成物" (1 times) , and the next most invalidation trial patent is 特許6950966 "スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法" (1 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6522072 | イズロン酸−２−スルファターゼのＣＮＳ送達のための方法および組成物 | 1 times |
| 2 | 特許6950966 | スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法 | 1 times |
| 3 | 特許6335326 | コンジュゲート化莢膜糖類抗原を含む免疫原性組成物およびその使用 | 1 times |
| 4 | 特許6236167 | 医薬品 | 1 times |
| 5 | 特許6896700 | ワクチン組成物 | 1 times |
Oppositioned cases
List of latest Oppositioned patents
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 26 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7425603 "医薬組成物" (Opposition day 2024-07-29) , next is 特許7425560 "固形製剤の製造方法" (Opposition day 2024-07-22) .
| - | No. | Title | Opposition days |
|---|---|---|---|
| 1 | 特許7425603 | 医薬組成物 | 2024-07-29 |
| 2 | 特許7425560 | 固形製剤の製造方法 | 2024-07-22 |
| 3 | 特許7512762 | スガマデクス含有の液体製剤 | 2024-07-11 |
| 4 | 特許7402687 | 医薬組成物 | 2024-06-21 |
| 5 | 特許7366515 | 外用組成物 | 2024-04-23 |
| 6 | 特許7448953 | 眼疾患のための細胞モデル及び治療関連出願への相互参照 | 2024-04-17 |
| 7 | 特許7346010 | 外用組成物 | 2024-03-19 |
| 8 | 特許7339261 | 低アレルゲン性の乳児用調製乳及びそれを調製する方法 | 2024-03-05 |
| 9 | 特許7348543 | メッセンジャーＲＮＡのカプセル化 | 2024-02-29 |
| 10 | 特許7305630 | Ｎ－アセチルノイラミン酸の発酵生産 | 2024-01-09 |
Protested cases
List of latest Protested patents
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 136 patents Protest from third parties. The average number of Protest is 1.8 times. The most recently Protest patent is 特開2021-143136 "染毛用組成物" (Protest day 2024-09-11) , next is 特開2022-071278 "酢酸ナトリウム結晶" (Protest day 2024-09-02) .
| - | No. | Title | Protest days |
|---|---|---|---|
| 1 | 特開2021-143136 | 染毛用組成物 | 2024-09-11 |
| 2 | 特開2022-071278 | 酢酸ナトリウム結晶 | 2024-09-02 |
| 3 | 特開2022-189088 | 口腔内病原細菌のバイオフィルム形成抑制剤、及び、口腔用製剤 | 2024-08-30 |
| 4 | 特開2024-099681 | 粒子、粒子含有組成物および粒子の製造方法 | 2024-08-30 |
| 5 | 特開2022-021943 | 外用組成物、マスク製剤 | 2024-08-30 |
| 6 | 特表2023-505246 | 無機物および／またはビタミンならびに多糖を含む製剤、その組成物ならびに前記無機物および／またはビタミンの補充におけるその使用 | 2024-08-22 |
| 7 | 特表2022-546587 | 生物製剤の捕捉及び精製のための方法 | 2024-08-22 |
| 8 | 特開2022-053739 | 洗浄組成物 | 2024-07-24 |
| 9 | 特開2024-096506 | 外用製剤 | 2024-07-24 |
| 10 | 特表2022-502482 | 骨損傷を治療するための組成物及び方法 | 2024-07-19 |
| 11 | 特表2023-525987 | 固体粘着性組成物 | 2024-07-18 |
| 12 | 特開2022-085736 | 皮膚外用剤 | 2024-07-16 |
| 13 | 特開2023-041726 | 外用製剤、液切れ性を改善する方法、および、液切れ性改善剤 | 2024-06-28 |
| 14 | 特開2019-151620 | 毛髪用組成物 | 2024-06-24 |
| 15 | 特表2023-517644 | コロナウイルスワクチン組成物及び方法 | 2024-06-15 |
| 16 | 特開2022-059984 | 溶解型マイクロニードル製剤 | 2024-06-14 |
| 17 | 特開2022-075943 | 医薬組成物 | 2024-05-02 |
| 18 | 特開2021-059525 | 水中油型乳化組成物、及び水中油型乳化組成物の液だれ抑制方法 | 2024-04-26 |
| 19 | 特開2022-151457 | 皮膚用組成物 | 2024-04-25 |
| 20 | 特開2022-043520 | ベリー系果汁入り鉄含有飲食品 | 2024-04-24 |
Top Patents/Patent Applications with the Highest Number of Protested
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 281 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.6. The most protest patent is 特開2018-177763 "トラネキサム酸類配合製剤" (9 times) , and the next most protest patent is 特許7346010 "外用組成物" (6 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特開2018-177763 | トラネキサム酸類配合製剤 | 9 times |
| 2 | 特許7346010 | 外用組成物 | 6 times |
| 3 | 特開2018-030829 | ロキソプロフェン含有の医薬製剤 | 6 times |
| 4 | 特開2016-193894 | 生菌含有製剤 | 6 times |
| 5 | 特許7366515 | 外用組成物 | 6 times |
Inspectioned cases
List of latest Inspectioned patents
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 442 patents Inspection from third parties. The average number of Inspection is 2.0 times. The most recently Inspection patent is 特許7565921 "急性骨髄性白血病の治療のための、ＣＤ７０及びベネトクラクス、ＢＣＬ－２阻害剤、組合せ療法" (Inspection day 2024-09-20) , next is 特許7565951 "皮下投与に好適なＦｃＲｎインヒビターの医薬製剤" (Inspection day 2024-09-20) .
| - | No. | Title | Inspection days |
|---|---|---|---|
| 1 | 特許7565921 | 急性骨髄性白血病の治療のための、ＣＤ７０及びベネトクラクス、ＢＣＬ－２阻害剤、組合せ療法 | 2024-09-20 |
| 2 | 特許7565951 | 皮下投与に好適なＦｃＲｎインヒビターの医薬製剤 | 2024-09-20 |
| 3 | 特表2022-519570 | 安定化Ｆｃ融合タンパク質溶液 | 2024-09-19 |
| 4 | 特開2024-096506 | 外用製剤 | 2024-09-17 |
| 5 | 特許7488634 | 外用製剤 | 2024-09-17 |
| 6 | 特表2023-517644 | コロナウイルスワクチン組成物及び方法 | 2024-09-13 |
| 7 | 特表2024-532019 | アルファ－１アンチトリプシン発現を阻害するための組成物及び方法 | 2024-09-06 |
| 8 | 特表2021-531022 | 環状ポリリボヌクレオチドを含む組成物及びその使用 | 2024-09-06 |
| 9 | 特開2021-091829 | 次亜塩素酸ナトリウム製剤 | 2024-09-05 |
| 10 | 特許7553357 | がんの処置のための組成物および方法 | 2024-09-05 |
| 11 | 特表2022-546587 | 生物製剤の捕捉及び精製のための方法 | 2024-08-28 |
| 12 | 特表2022-502482 | 骨損傷を治療するための組成物及び方法 | 2024-08-15 |
| 13 | 特開2022-085736 | 皮膚外用剤 | 2024-08-09 |
| 14 | 特表2024-511488 | 副腎皮質刺激ホルモンまたはその誘導体を含有する薬物およびその使用 | 2024-08-06 |
| 15 | 特表2021-514661 | サイトカインに連結させたＥＣＭ親和性ペプチドを用いてがんを処置するための方法および組成物 | 2024-07-30 |
| 16 | 特開2022-088355 | 結合タンパク質及びその使用方法 | 2024-07-29 |
| 17 | 特表2023-525987 | 固体粘着性組成物 | 2024-07-24 |
| 18 | 特表2021-518345 | 喘息またはアレルギー性疾患を処置するための方法 | 2024-07-23 |
| 19 | 特開2019-151620 | 毛髪用組成物 | 2024-07-17 |
| 20 | 特表2021-500413 | 一部の肉腫の治療に使用するためのＩＬ−８阻害薬 | 2024-07-09 |
Top Patents/Patent Applications with the Highest Number of Inspectioned
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 835 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.6. The most inspection patent is 特許6142892 "経口投与用医薬組成物" (30 times) , and the next most inspection patent is 特表2017-504615 "パロノセトロンを含有する薬学組成物" (16 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6142892 | 経口投与用医薬組成物 | 30 times |
| 2 | 特表2017-504615 | パロノセトロンを含有する薬学組成物 | 16 times |
| 3 | 特許6095725 | ベンゾチオフェン類、それを含む製剤、および方法 | 15 times |
| 4 | 特許7265834 | 植物エキス末の製造方法 | 15 times |
| 5 | 特許6327237 | 固形組成物 | 14 times |
Cited cases
Top Patents/Patent Applications with the Highest Number of Cited
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 3,049 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.1. The most cited patent is 特許6653432 "気化装置のシステムおよび方法" (67 times) , and the next most cited patent is 特許6785819 "ＫＲＡＳ Ｇ１２Ｃ阻害剤及びその使用方法" (31 times) .
| - | No. | Title | |
|---|---|---|---|
| 1 | 特許6653432 | 気化装置のシステムおよび方法 | 67 times |
| 2 | 特許6785819 | ＫＲＡＳ Ｇ１２Ｃ阻害剤及びその使用方法 | 31 times |
| 3 | 特表2019-521739 | 電子気化器の制御 | 26 times |
| 4 | 特許6092945 | 多発性硬化症を治療するためのクラドリビン投薬計画 | 25 times |
| 5 | 特許7149276 | ＰＤ－Ｌ１内在化誘導物質としてのテトラヒドロイミダゾ［４，５－Ｃ］ピリジン誘導体 | 24 times |
Providing patent information to the media (newspapers, magazines, etc.)
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
About this Site
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
Please note the following points for use.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
Citation of patent application status and ranking information
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Graphs are image data.
Please note that the various graphs are image data, but we cannot provide them in text data.Scope of coverage for each goal/target
- Based on the description of each goal and target of the SDGs, we have set the scope of technologies to be covered based on our and e-Patent's past experience, etc. (in some cases, the search is based on social issues themselves). Therefore, please note that there is a possibility that this "SDGs Global Company Ranking from Patent Perspective" may not cover 100%.
- A population search formula is clearly indicated for each goal/target (database: Patent Integration). You may use the population search formula as it is, or you may improve it by yourself.
- This search covers patents and utility models, including both published and registered patents (design and design patents are excluded). The unit of count is the number of applications, not the number of patent families.
About the name collation and name control of applicants and right holders
- Company rankings are based on the results calculated by "Patent Integration", with Japanese organizations in Japanese and other companies in English (some are in Japanese).
- Company names may be the names of the companies at the time of application, but the results calculated by Patent Integration are used as is. Company names are used as they were at the time of application.
- Because of the fluctuation in the names of companies (i.e., applicant/right holder names in the patent information), there are cases where the same company appears more than once in the top 10. The number of applications filed by the same company in the top 10 is the total number of applications filed by the company.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International
Our Commitment to Safety and Security
Patent Integration Co., Ltd. is committed to providing high-quality patent information based on the latest patent data on more than 45 million cases collected from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publication. 
Patent Integration Co., Ltd. collects the patent data from the Patent Offices in Japan, the U.S., Europe, and Taiwan and from PCT publications to provide it widely in the form of reports so that anyone can check patent information and patent trends with confidence. 
Patent Integration Co., Ltd. is committed to various efforts to enhance the reliability of the information and to allow users to search patent information with confidence.